Intrauterine L-NAME Exposure Weakens the Development of Sympathetic Innervation and Induces the Remodeling of Arterial Vessels in Two-Week-Old Rats

Int J Mol Sci. 2021 Nov 15;22(22):12327. doi: 10.3390/ijms222212327.

Abstract

Nitric oxide (NO) has been shown to stimulate differentiation and increase the survival of ganglionic sympathetic neurons. The proportion of neuronal NOS-immunoreactive sympathetic preganglionic neurons is particularly high in newborn rats and decreases with maturation. However, the role of NO in the development of vascular sympathetic innervation has never been studied before. We tested the hypothesis that intrauterine NO deficiency weakened the development of vascular sympathetic innervation and thereby changed the contractility of peripheral arteries and blood pressure level in two-week-old offspring. Pregnant rats consumed NOS inhibitor L-NAME (250 mg/L in drinking water) from gestational day 10 until delivery. Pups in the L-NAME group had a reduced body weight and blood level of NO metabolites at 1-2 postnatal days. Saphenous arteries from two-week-old L-NAME offspring demonstrated a lower density of sympathetic innervation, a smaller inner diameter, reduced maximal active force and decreased α-actin/β-actin mRNA expression ratio compared to the controls. Importantly, pups in the L-NAME group exhibited decreased blood pressure levels before, but not after, ganglionic blockade with chlorisondamine. In conclusion, intrauterine L-NAME exposure is followed by the impaired development of the sympathetic nervous system in early postnatal life, which is accompanied by the structural and functional remodeling of arterial blood vessels.

Keywords: blood pressure; early postnatal development; nitric oxide; sympathetic innervation; vasculature.

MeSH terms

  • Animals
  • Animals, Newborn
  • Arteries / innervation*
  • Arteries / metabolism
  • Blood Pressure / drug effects
  • Body Weight / drug effects
  • Enzyme Inhibitors / pharmacology*
  • Female
  • Gestational Age
  • Male
  • Models, Animal
  • NG-Nitroarginine Methyl Ester / pharmacology*
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • Nitric Oxide Synthase / metabolism
  • Pregnancy
  • Rats
  • Rats, Wistar
  • Sympathetic Nervous System / embryology*
  • Sympathetic Nervous System / growth & development*
  • Sympathetic Nervous System / metabolism
  • Vascular Remodeling / drug effects*

Substances

  • Enzyme Inhibitors
  • Nitric Oxide
  • Nitric Oxide Synthase
  • NG-Nitroarginine Methyl Ester